These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35366768)

  • 41. Roles of long noncoding RNAs in gastric cancer and their clinical applications.
    Sun W; Yang Y; Xu C; Xie Y; Guo J
    J Cancer Res Clin Oncol; 2016 Nov; 142(11):2231-7. PubMed ID: 27246953
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Non-coding RNAs: long non-coding RNAs and microRNAs in endocrine-related cancers.
    Klinge CM
    Endocr Relat Cancer; 2018 Apr; 25(4):R259-R282. PubMed ID: 29440232
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MiR-129 regulates cisplatin-resistance in human gastric cancer cells by targeting P-gp.
    Lu C; Shan Z; Li C; Yang L
    Biomed Pharmacother; 2017 Feb; 86():450-456. PubMed ID: 28012924
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overexpression of long non-coding RNA GHET1 promotes the development of multidrug resistance in gastric cancer cells.
    Zhang X; Bo P; Liu L; Zhang X; Li J
    Biomed Pharmacother; 2017 Aug; 92():580-585. PubMed ID: 28578256
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MiR-218 inhibits multidrug resistance (MDR) of gastric cancer cells by targeting Hedgehog/smoothened.
    Zhang XL; Shi HJ; Wang JP; Tang HS; Cui SZ
    Int J Clin Exp Pathol; 2015; 8(6):6397-406. PubMed ID: 26261515
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Integrated analysis of a ceRNA network reveals potential prognostic lncRNAs in gastric cancer.
    Qi M; Yu B; Yu H; Li F
    Cancer Med; 2020 Mar; 9(5):1798-1817. PubMed ID: 31923354
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Roles of ncRNAs as ceRNAs in Gastric Cancer.
    Ye J; Li J; Zhao P
    Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356052
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Deciphering the Role of Exosomal Non-Coding RNA (ncRNA) in Drug Resistance of Gastrointestinal Tumors; an Updated Review.
    Tashakori N; Armanfar M; Mashhadi A; Mohammed AT; Karim MM; Hussein AHA; Adil M; Azimi SA; Abedini F
    Cell Biochem Biophys; 2024 Jun; 82(2):609-621. PubMed ID: 38878101
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Construction of a competing endogenous RNA network and identification of potential regulatory axes in gastric cancer chemoresistance.
    Yang XZ; Ma L; Fang SX; Song Y; Zhu SY; Jin C; Liu W; Lu Q; Zeng LS; Cui SZ
    Pathol Res Pract; 2022 Jun; 234():153904. PubMed ID: 35487029
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long noncoding RNAs in gastric cancer carcinogenesis and metastasis.
    Nasrollahzadeh-Khakiani M; Emadi-Baygi M; Schulz WA; Nikpour P
    Brief Funct Genomics; 2017 May; 16(3):129-145. PubMed ID: 27122631
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.
    Rodríguez Bautista R; Ortega Gómez A; Hidalgo Miranda A; Zentella Dehesa A; Villarreal-Garza C; Ávila-Moreno F; Arrieta O
    Clin Epigenetics; 2018; 10():88. PubMed ID: 29983835
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Primate-specific Long Non-coding RNAs and MicroRNAs.
    Awan HM; Shah A; Rashid F; Shan G
    Genomics Proteomics Bioinformatics; 2017 Jun; 15(3):187-195. PubMed ID: 28602844
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review.
    Huang YK; Yu JC
    World J Gastroenterol; 2015 Sep; 21(34):9863-86. PubMed ID: 26379393
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular pathways involved in microRNA-mediated regulation of multidrug resistance.
    Liao R; Lin Y; Zhu L
    Mol Biol Rep; 2018 Dec; 45(6):2913-2923. PubMed ID: 30194558
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Microarray analysis of long non-coding RNAs related to microRNA-148b in gastric cancer.
    Song Y; Sun J; Xu Y; Liu J; Gao P; Chen X; Zhao J; Wang Z
    Neoplasma; 2017; 64(2):199-208. PubMed ID: 28043146
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic targeting of non-coding RNAs in cancer.
    Slaby O; Laga R; Sedlacek O
    Biochem J; 2017 Dec; 474(24):4219-4251. PubMed ID: 29242381
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Crosstalk between lncRNAs and miRNAs in gastrointestinal cancer drug resistance.
    Raei N; Safaralizadeh R; Hesseinpourfeizi M; Yazdanbod A; Pourfarzi F; Latifi-Navid S
    Life Sci; 2021 Nov; 284():119933. PubMed ID: 34508759
    [TBL] [Abstract][Full Text] [Related]  

  • 58. LncRNAs as potential diagnostic and prognostic biomarkers in gastric cancer: A novel approach to personalized medicine.
    Fattahi S; Kosari-Monfared M; Golpour M; Emami Z; Ghasemiyan M; Nouri M; Akhavan-Niaki H
    J Cell Physiol; 2020 Apr; 235(4):3189-3206. PubMed ID: 31595495
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Non-coding RNA in drug resistance of hepatocellular carcinoma.
    Ding B; Lou W; Xu L; Fan W
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30224380
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Non-coding RNA dysregulation in skin cancers.
    Durante G; Comito F; Lambertini M; Broseghini E; Dika E; Ferracin M
    Essays Biochem; 2021 Oct; 65(4):641-655. PubMed ID: 34414406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.